Atlas Trials

Trastuzumab in Combination With AMG 479 in HER-2 Overexpressing MBC Progressing on Trastuzumab

Clinical trial NCT01479179 · WITHDRAWN

Trial details

NCT number
NCT01479179
Sponsor
M.D. Anderson Cancer Center
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2012-11-01
Primary completion
2015-11-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.